Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical significance of P-glycoprotein in multidrug resistance malignancies.

× No keyword cloud information.

30 in total

Review 1. Nanomedicinal strategies to treat multidrug-resistant tumors: current progress.

Authors: Xiaowei Dong; Russell J Mumper
Journal: Nanomedicine (Lond) Date: 2010-06 Impact factor: 5.307

2. The MYND motif is required for repression of basal transcription from the multidrug resistance 1 promoter by the t(8;21) fusion protein.

Authors: B Lutterbach; D Sun; J Schuetz; S W Hiebert
Journal: Mol Cell Biol Date: 1998-06 Impact factor: 4.272

3. Direct assessment of P-glycoprotein efflux to determine tumor response to chemotherapy.

Authors: Gauri Patwardhan; Vineet Gupta; Juowen Huang; Xin Gu; Yong-Yu Liu
Journal: Biochem Pharmacol Date: 2010-03-16 Impact factor: 5.858

4. Phase I study of valspodar (PSC-833) with mitoxantrone and etoposide in refractory and relapsed pediatric acute leukemia: a report from the Children's Oncology Group.

Authors: Maureen M O'Brien; Norman J Lacayo; Bert L Lum; Smita Kshirsagar; Steven Buck; Yaddanapudi Ravindranath; Mark Bernstein; Howard Weinstein; Myron N Chang; Robert J Arceci; Branimir I Sikic; Gary V Dahl
Journal: Pediatr Blood Cancer Date: 2010-05 Impact factor: 3.167

5. Differential effects of mitomycin C and doxorubicin on P-glycoprotein expression.

Authors: R Maitra; P A Halpin; K H Karlson; R L Page; D Y Paik; M O Leavitt; B D Moyer; B A Stanton; J W Hamilton
Journal: Biochem J Date: 2001-05-01 Impact factor: 3.857

6. Ultrasound-Induced hyperthermia increases cellular uptake and cytotoxicity of P-glycoprotein substrates in multi-drug resistant cells.

Authors: Y Liu; C W Cho; X Yan; T K Henthorn; K O Lillehei; W N Cobb; K Y Ng
Journal: Pharm Res Date: 2001-09 Impact factor: 4.200

Clinical significance of P-glycoprotein in multidrug resistance malignancies.

Review 1. Nanomedicinal strategies to treat multidrug-resistant tumors: current progress.

2. The MYND motif is required for repression of basal transcription from the multidrug resistance 1 promoter by the t(8;21) fusion protein.

3. Direct assessment of P-glycoprotein efflux to determine tumor response to chemotherapy.

4. Phase I study of valspodar (PSC-833) with mitoxantrone and etoposide in refractory and relapsed pediatric acute leukemia: a report from the Children's Oncology Group.

5. Differential effects of mitomycin C and doxorubicin on P-glycoprotein expression.

6. Ultrasound-Induced hyperthermia increases cellular uptake and cytotoxicity of P-glycoprotein substrates in multi-drug resistant cells.

7. Gene expression signatures and ex vivo drug sensitivity profiles in children with acute lymphoblastic leukemia.

Review 8. Important issues in high dose chemotherapy and stem cell transplantation.

Review 9. Molecular biology of leukemia for the clinician.

10. N-(2-Hydroxypropyl)methacrylamide Copolymer-Drug Conjugates for Combination Chemotherapy of Acute Myeloid Leukemia.